Karim Mikhail

Acting director, FDA Center for Biologics Evaluation and Research (CBER)

Appears in 1 story

Stories

FDA licenses first US freeze-dried plasma product

New Capabilities

Oversaw the Ezplaz licensure

For decades, US plasma transfusions required a freezer and time to thaw. Ezplaz, the first US-licensed freeze-dried plasma, reconstitutes in about 2.5 minutes and sits on a shelf for a year.

Updated Yesterday